Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Stroke. 2022 Jun 3;53(7):2369–2376. doi: 10.1161/STROKEAHA.121.037358

Figure 1: Experimental timeline and protocol.

Figure 1:

(A) Experimental timeline showing the timing of assessments and interventions. (B) A representative hematoxylin/eosin-stained coronal section showing the angle and location of L-NIO injection (arrow) and resulting corpus callosum lesion at day 35. (C) Dorsal field of view of the cranial window as well as the RSFC images. Intact skull transparency was achieved by a chronic cover glass preparation. The approximate location of the L-NIO lesion is also shown.